<doc>
  <docmeta id="113hr4640ih">
    <bill congress="113" type="hr" number="4640" version="ih"/>
    <revision size="15572" annotations="0" status="complete" id="5" commit-time="2014-05-27T15:43:23Z" committer="mbohmer" doc="113hr4640ih/5.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H5AF7971B88BB4DB9A90F8500FBCB54AA" public-private="public">
	<metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 4640 IH: Western Hemisphere Drug Policy Commission Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-05-09</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>2d Session</session>
		<legis-num>H. R. 4640</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20140509">May 9, 2014</action-date>
			<action-desc>
        <sponsor name-id="E000179">Mr. Engel</sponsor> (for himself, <cosponsor name-id="S000018">Mr. Salmon</cosponsor>, <cosponsor name-id="S001165">Mr. Sires</cosponsor>, <cosponsor name-id="R000435">Ms. Ros-Lehtinen</cosponsor>, and <cosponsor name-id="O000170">Mr. O’Rourke</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HFA00">Committee on Foreign Affairs</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To establish the Western Hemisphere Drug Policy Commission.</official-title>
	</form>
	<legis-body id="HF6A213A746C645EAA643A265D668FBE4" style="OLC">
		<section id="H7101B535150647D688C5FB27F0090944" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>
            <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Western Hemisphere Drug Policy Commission Act of 2014" proposed="true">Western Hemisphere Drug Policy Commission Act of 2014</cato:entity-ref>
          </short-title>
        </quote>.</text>
		</section>
    <section id="H80363100679A4ADFA7A8F88FC58D187F">
      <enum>2.</enum>
      <header>Findings</header>
      <text display-inline="no-display-inline">
        <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> finds the following:</text>
			<paragraph id="HBBAD3553D7C5491081CEEDCD51B8D924">
        <enum>(1)</enum>
        <text>According to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7522" entity-type="federal-body">Substance Abuse and Mental Health Services Administration</cato:entity-ref>’s (SAMHSA) National
			 Survey on Drug Use and Health, in 2012 in the United States, an estimated
			 23,900,000 persons age 12 or older were current drug users. There were an
			 estimated 1,600,000 users of cocaine, 440,000 users of methamphetamine,
			 335,000 users of heroin, 18,900,000 users of marijuana, and 6,800,000
			 non-medical users of prescription-type drugs.</text>
			</paragraph>
      <paragraph id="H51A4288D1F114BBB9E891962BEE6FDFF">
        <enum>(2)</enum>
        <text>On September 13, 2013, President Barack Obama identified 22 countries as major drug transit or
			 major illicit drug producing countries. Of these, 17 are located in the
			 Western Hemisphere. They are The Bahamas, Belize, Bolivia, Colombia, Costa
			 Rica, the Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti,
			 Honduras, Jamaica, Mexico, Nicaragua, Panama, Peru, and Venezuela.</text>
			</paragraph>
      <paragraph id="H9334DC6CB1464C96859BCBD90F3FFF1F">
        <enum>(3)</enum>
        <text>Nearly all cocaine consumed in the United States originates in the Andean countries of Bolivia,
			 Colombia, and Peru and most of the heroin consumed in the United States
			 originates in Colombia and Mexico. The cultivation, production and
			 trafficking of cocaine and heroin generate violence, instability, and
			 corruption.</text>
			</paragraph>
      <paragraph id="H532AFA60FD7B4FFDA05DA0D6EE048696">
        <enum>(4)</enum>
        <text>In the transit countries of Central America, Mexico, Venezuela, Ecuador, the Dominican Republic,
			 Haiti, and other Caribbean countries, drug trafficking is central to the
			 growing strength of organized criminals to threaten local and national law
			 enforcement, political institutions, citizen security, rule of law, and
			 United States security and interests.</text>
			</paragraph>
      <paragraph id="HFC7CE0217D9D44BB95432073A7014D2A">
        <enum>(5)</enum>
        <text>Drug trafficking-related violence continues unabated in Mexico. According to Government of Mexico
			 estimates, some 70,000 people died in Mexico and 25,000 people disappeared
			 as a result of drug trafficking and organized crime-related violence
			 between December 2006 and December 2012. According to analysts, more than
			 11,500 more people died in Mexico in 2013 due to the violence.</text>
			</paragraph>
      <paragraph id="HF4AA48AB54294CB5996F2BC6A176CD06">
        <enum>(6)</enum>
        <text>Foreign Terrorist Organizations and their supporters in the Western Hemisphere, including the
			 Revolutionary Armed Forces of Colombia (FARC) and Hezbollah, have used
			 drug trafficking to finance their activities.</text>
			</paragraph>
      <paragraph id="H6CE3247D9F094F5B930BF60256797E3B">
        <enum>(7)</enum>
        <text>The United States obligated roughly $15,700,000,000 ($18,600,000,000 in constant 2012 dollars) for
			 counternarcotics programs in Latin America and the Caribbean between 1980
			 and 2012.</text>
			</paragraph>
    </section>
    <section id="H4A12D05B670A4107B79CE9693623D110">
      <enum>3.</enum>
      <header>Establishment</header>
      <text display-inline="no-display-inline">There is established an independent commission to be known as the <quote>
          <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Western Hemisphere Drug Policy Commission</cato:entity-ref>
        </quote> (in this Act referred to as the <quote>Commission</quote>).</text>
		</section>
    <section id="H72165D1948B648E0A59EF71AF26645F9">
      <enum>4.</enum>
      <header>Duties</header>
			<subsection id="HE613994E97FB42858D063F94BB3D1C45">
        <enum>(a)</enum>
        <header>Review of illicit drug control policies</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> shall conduct a comprehensive review of United States foreign policy in the Western
			 Hemisphere to reduce the illicit drug supply and drug abuse and reduce the
			 damage associated with illicit drug markets and trafficking. The
			 Commission shall also identify policy and program options to improve
			 existing international counternarcotics policy. The review shall include
			 the following topics:</text>
				<paragraph id="H7EBCA735A84E42A29838D84905FF57CD">
          <enum>(1)</enum>
          <text>An evaluation of United States-funded international illicit drug control programs in the Western
			 Hemisphere, including drug interdiction, crop eradication, alternative
			 development, drug production surveys, police and justice sector training,
			 demand reduction, and strategies to target drug kingpins.</text>
				</paragraph>
        <paragraph id="HFA1C4718833A4F1C9FB20C15549B24EA">
          <enum>(2)</enum>
          <text>An evaluation of the impact of United States counternarcotics assistance programs in the Western
			 Hemisphere, including the Colombia Strategic Development Initiative, the
			 Merida Initiative, the Caribbean Basin Security Initiative and the Central
			 America Regional Security Initiative, in curbing drug production, drug
			 trafficking, and drug-related violence and improving citizen security.</text>
				</paragraph>
        <paragraph id="H6539CAE74C844EF1849D865B7E1F9500">
          <enum>(3)</enum>
          <text>An evaluation of how the President’s annual determination of major drug-transit and major illicit
			 drug producing countries pursuant to <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Foreign Assistance Act of 1961/s:490">sections 490 of the Foreign
			 Assistance Act of 1961</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/22/2291j">
              <cato:entity-ref entity-type="uscode" value="usc/22/2291j">22 U.S.C. 2291j</cato:entity-ref>
            </external-xref>)</cato:entity> and <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Foreign Relations Authorization Act, Fiscal Year 2003/s:706">section 706 of the Foreign
			 Relations Authorization Act, Fiscal Year 2003</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/22/2291j-1">
              <cato:entity-ref entity-type="uscode" value="usc/22/2291j–1">22 U.S.C. 2291j–1</cato:entity-ref>
              </external-xref>)</cato:entity> serves
			 United States interests with respect to United States international
			 illicit drug control policies.</text>
				</paragraph>
        <paragraph id="HB717E41175D04E70BACE562522C3285F">
          <enum>(4)</enum>
          <text>An evaluation of whether the proper indicators of success are being used to evaluate United States
			 international illicit drug control policy.</text>
				</paragraph>
        <paragraph id="H42F1B43E9CD84478807380915F819AB9">
          <enum>(5)</enum>
          <text>An evaluation of United States efforts to stop illicit proceeds from drug trafficking organizations
			 from entering the United States financial system.</text>
				</paragraph>
        <paragraph id="H02607C366EB54127B3C8A77CE565D286">
          <enum>(6)</enum>
          <text>An evaluation of alternative drug policy models in the Western Hemisphere.</text>
				</paragraph>
        <paragraph id="H5ECB4A95116B401AA02031C3CC8D1DCC">
          <enum>(7)</enum>
          <text>An evaluation of the impact of local drug consumption in Latin America and the Caribbean in
			 promoting violence and insecurity.</text>
				</paragraph>
        <paragraph id="H0C5B75168287486DBD7DA99F33FA8E6F">
          <enum>(8)</enum>
          <text>Recommendations on how best to improve United States counternarcotics policies in the Western
			 Hemisphere.</text>
				</paragraph>
      </subsection>
      <subsection id="HDBF3D83D87DA4F3286919A3B4DB05BC2">
        <enum>(b)</enum>
        <header>Coordination with governments, international organizations, and nongovernmental organizations in
			 the Western Hemisphere</header>
        <text>In conducting the review required under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Western Hemisphere Drug Policy Commission Act of 2014/s:4/ss:a" proposed="true">subsection (a)</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> is encouraged to consult
			 with—</text>
				<paragraph id="H415607C5FFF94F3EB5B51E87C77B8F22">
          <enum>(1)</enum>
          <text>government, academic, and nongovernmental leaders, as well as leaders from international
			 organizations, from throughout the United States, Latin America, and the
			 Caribbean; and</text>
				</paragraph>
        <paragraph id="H359F0776CE8D468CBD1571A27A9559A9">
          <enum>(2)</enum>
          <text>the Inter-American Drug Abuse Control Commission (CICAD).</text>
				</paragraph>
      </subsection>
      <subsection id="HA4A87F0218C74BE1811C10F82D6DBECA">
        <enum>(c)</enum>
        <header>Report</header>
				<paragraph id="H6FD1C6FE11FD47EAB2BEC8FCE7989F54">
          <enum>(1)</enum>
          <header>In general</header>
          <text>Not later than 1 year after the first meeting of the Commission, the Commission shall submit to the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="HFA00" entity-type="committee">Committee on Foreign Affairs of the House of Representatives</cato:entity-ref>, the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="SSFR00" entity-type="committee">Committee on Foreign Relations of the Senate</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1900" entity-type="federal-body">Secretary of State</cato:entity-ref>, and
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1127" entity-type="federal-body">Director of the Office of National Drug Control Policy</cato:entity-ref> a report that
			 contains—</text>
					<subparagraph id="H88052827F9D444F9907292D648DEB7CB">
            <enum>(A)</enum>
            <text>a detailed statement of the recommendations, findings, and conclusions of the Commission under
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Western Hemisphere Drug Policy Commission Act of 2014/s:4/ss:a" proposed="true">subsection (a)</cato:entity-ref>; and</text>
					</subparagraph>
          <subparagraph id="H5612AF4993044D95B4C0C6B82B17C7F3">
            <enum>(B)</enum>
            <text>summaries of the input and recommendations of the leaders and organizations with which the
			 Commission consulted under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Western Hemisphere Drug Policy Commission Act of 2014/s:4/ss:b" proposed="true">subsection (b)</cato:entity-ref>.</text>
					</subparagraph>
        </paragraph>
        <paragraph id="HDC74192BD0234FD59A77E9D045033E1A">
          <enum>(2)</enum>
          <header>Public availability</header>
          <text>The report required under this subsection shall be made available to the public.</text>
				</paragraph>
      </subsection>
    </section>
    <section id="HDB4EA6AD0F3D49EA8D6CBA6E024D366E">
      <enum>5.</enum>
      <header>Membership</header>
			<subsection id="H6972CE01496F4034BED4539F21F0CF29">
        <enum>(a)</enum>
        <header>Number and appointment</header>
        <text>The Commission shall be composed of ten members to be appointed as follows:</text>
				<paragraph id="HAF2D98E123B643A9BD7F7B188CA9C2DB">
          <enum>(1)</enum>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Majority Leader of the Senate" entity-parent-id="0010">majority leader</cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Minority Leader of the Senate" entity-parent-id="0010">minority leader of the Senate</cato:entity-ref> shall each appoint 2 members.</text>
				</paragraph>
        <paragraph id="H67EAE344C4474D4887858318F97B0CA7">
          <enum>(2)</enum>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Speaker of the House of Representatives" entity-parent-id="0050">Speaker</cato:entity-ref> and the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Minority Leader of the House of Representatives" entity-parent-id="0050">minority leader of the House of Representatives</cato:entity-ref> shall each appoint 2 members.</text>
				</paragraph>
        <paragraph id="HD8FAF1DC915D4595BA4DE066E8AAB751">
          <enum>(3)</enum>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="1100">President</cato:entity-ref> shall appoint 2 members.</text>
				</paragraph>
      </subsection>
      <subsection id="H7099639FB37D4435AB7F0BC000C2D4A1">
        <enum>(b)</enum>
        <header>Prohibition</header>
				<paragraph id="H30861B3CD4E441B39D09C911BF0C5F3B">
          <enum>(1)</enum>
          <header>In general</header>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> may not include Members of Congress or Federal, State, or local government
			 officials.</text>
				</paragraph>
        <paragraph commented="no" id="HAC1A010CBD6D4BCA89224DA31D3F8940">
          <enum>(2)</enum>
          <header>Member of Congress</header>
          <text>In this subsection, the term <term>Member of Congress</term> includes a Delegate or Resident Commissioner to the Congress.</text>
				</paragraph>
      </subsection>
      <subsection id="HD8164DD43E344B4FABE387AEBDF76D30">
        <enum>(c)</enum>
        <header>Period of appointment</header>
        <text>Each member shall be appointed for the life of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>. Any vacancies shall not affect the
			 power and duties of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>, but shall be filled in the same manner
			 as the original appointment.</text>
			</subsection>
      <subsection id="H941A3451AB20425285ED588ECCF82CD8">
        <enum>(d)</enum>
        <header>Date</header>
        <text>Members of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> shall be appointed not later than 30 days after the date of the enactment
			 of this Act.</text>
			</subsection>
      <subsection id="H86C8439A593F448BA5125E2ABCDDD675">
        <enum>(e)</enum>
        <header>Initial meeting and selection of chairperson</header>
				<paragraph id="H07CCB115E82C449BA56893559C0E0867">
          <enum>(1)</enum>
          <header>In general</header>
          <text>Not later than 60 days after the date of the enactment of this Act, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> shall hold an
			 initial meeting to develop and implement a schedule for completion of the
			 review and report required under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Western Hemisphere Drug Policy Commission Act of 2014/s:4" proposed="true">section 4</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="H591A9851869C40E696D2208522A9E6C7">
          <enum>(2)</enum>
          <header>Chairperson</header>
          <text>At the initial meeting, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> shall select a Chairperson from among its members.</text>
				</paragraph>
      </subsection>
      <subsection id="HEE3C75EDD3404D59987CBA8CA739B10B">
        <enum>(f)</enum>
        <header>Quorum</header>
        <text>Six members of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> shall constitute a quorum.</text>
			</subsection>
      <subsection id="H7DCB63D3308F47CCB6049A9EE9F596A7">
        <enum>(g)</enum>
        <header>Travel expenses</header>
        <text>Members shall receive travel expenses, including per diem in lieu of subsistence, in accordance
			 with <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/5/5702">sections <external-xref legal-doc="usc" parsable-cite="usc/5/5702">5702</external-xref>
          </cato:entity-ref> and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/5/5703">
            <external-xref legal-doc="usc" parsable-cite="usc/5/5703">5703</external-xref> of title 5, United States Code</cato:entity-ref>, while away
			 from their homes or regular places of business in performance of services
			 for the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>.</text>
			</subsection>
    </section>
    <section id="H0F0E57CC369747008F86ACA0D5506335">
      <enum>6.</enum>
      <header>Powers</header>
			<subsection id="H8BAB1031E4C1435DBB21778457065932">
        <enum>(a)</enum>
        <header>Meetings</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> shall meet at the call of the Chairperson or a majority of its members.</text>
			</subsection>
      <subsection id="HDAF3AD8B9FA445119FD6B130479E55AD">
        <enum>(b)</enum>
        <header>Hearings</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> shall hold such hearings and undertake such other activities as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>
			 determines necessary to carry out its duties.</text>
			</subsection>
      <subsection id="H2C6D9E6F4D4345D5B34199516B7B644D">
        <enum>(c)</enum>
        <header>Other resources</header>
				<paragraph id="HBB2889787B2B4D31B2BE5BE967B4362D">
          <enum>(1)</enum>
          <header>Documents, statistical data, and other such information</header>
					<subparagraph id="HD4D28FE2FD7A42C9A35E2445BB5391AF">
            <enum>(A)</enum>
            <header>In general</header>
            <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> shall have reasonable access to documents, statistical data, and other such
			 information the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> determines necessary to carry out its duties
			 from the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0300">Library of Congress</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1127" entity-type="federal-body">Office of National Drug Control Policy</cato:entity-ref>,
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="1900" entity-type="federal-body">Department of State</cato:entity-ref>, and other agencies of the executive and
			 legislative branches of the Federal Government.</text>
					</subparagraph>
          <subparagraph id="H283258CC15B247A387E3CAEBB0A3DB12">
            <enum>(B)</enum>
            <header>Obtaining information</header>
            <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Chairperson of the Commission</cato:entity-ref> shall request the head of an agency described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Western Hemisphere Drug Policy Commission Act of 2014/s:6/ss:c/p:1/sp:A" proposed="true">subparagraph (A)</cato:entity-ref>
			 for access to documents, statistical data, or other such information
			 described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Western Hemisphere Drug Policy Commission Act of 2014/s:6/ss:c/p:1/sp:A" proposed="true">subparagraph (A)</cato:entity-ref> that is under the control of such agency in
			 writing when necessary.</text>
					</subparagraph>
        </paragraph>
        <paragraph id="HBD6CE112447648D8BCCE305F2C56FAA7">
          <enum>(2)</enum>
          <header>Office space and administrative support</header>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="4700" entity-type="federal-body">General Services Administration</cato:entity-ref> shall make office space available for day-to-day activities of
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> and for scheduled meetings of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>. Upon request,
			 the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="4700" entity-type="federal-body">Administrator of General Services</cato:entity-ref> shall provide, on a reimbursable
			 basis, such administrative support as the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> requests to fulfill
			 its duties.</text>
				</paragraph>
      </subsection>
      <subsection id="H28EEBC9EA5E9435B8519A142CF6B76B0">
        <enum>(d)</enum>
        <header>Authority To use United States mails</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> may use the United States mails in the same manner and under the same conditions as
			 other departments and agencies of the United States.</text>
			</subsection>
      <subsection id="HF1C1D2CB14F343CBB17A94953DC12077">
        <enum>(e)</enum>
        <header>Authority To contract</header>
				<paragraph id="H778EBAFBDE4C419AAC70F374D12C4F94">
          <enum>(1)</enum>
          <header>In general</header>
          <text>Subject to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Federal Property and Administrative Services Act of 1949">Federal Property and Administrative Services Act of 1949</cato:entity-ref>, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> is
			 authorized to enter into contracts with Federal and State agencies,
			 private firms, institutions, and individuals for the conduct of activities
			 necessary to the discharge of its duties under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Western Hemisphere Drug Policy Commission Act of 2014/s:4" proposed="true">section 4</cato:entity-ref>.</text>
				</paragraph>
        <paragraph id="H38D12839CCB04E81B6DDAB6E6994AA95">
          <enum>(2)</enum>
          <header>Termination</header>
          <text>A contract, lease, or other legal agreement entered into by the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> may not extend beyond
			 the date of termination of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>.</text>
				</paragraph>
      </subsection>
    </section>
    <section id="H034E8BF61E7C4812B17783D2A435CB0D">
      <enum>7.</enum>
      <header>Staff</header>
			<subsection id="H7A5C38A503B249708A3CFE3E7AA4D978">
        <enum>(a)</enum>
        <header>Director</header>
        <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> shall have a Director who shall be appointed by a majority vote of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>.
			 The Director shall be paid at a rate not to exceed the rate of basic pay
			 for level IV of the Executive Schedule.</text>
			</subsection>
      <subsection id="H1EC4C59056284F31B4921C6756050955">
        <enum>(b)</enum>
        <header>Staff</header>
				<paragraph id="H7363560E267246A4AFECFA3432E5F20E">
          <enum>(1)</enum>
          <header>In general</header>
          <text display-inline="yes-display-inline">With the approval of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>, the Director may appoint such personnel as the Director
			 determines to be appropriate. Such personnel shall be paid at a rate not
			 to exceed the rate of basic pay for level IV of the Executive Schedule.</text>
				</paragraph>
        <paragraph id="H306F2B5764C944FAB5495A44BD05C36A">
          <enum>(2)</enum>
          <header>Additional staff</header>
          <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> may appoint and fix the compensation of such other personnel as may be necessary to
			 enable the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> to carry out its duties, without regard to the
			 provisions of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/5">title 5, United States Code</cato:entity-ref>, governing appointments in the
			 competitive service, and without regard to the provisions of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc-chapter/5/51">chapter 51</cato:entity-ref>
			 and <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc-chapter/5/53/III">subchapter III of chapter 53 of such title</cato:entity-ref> relating to classification
			 and General Schedule pay rates, except that no rate of pay fixed under
			 this subsection may exceed the equivalent of that payable to a person
			 occupying a position at level V of the Executive Schedule.</text>
				</paragraph>
      </subsection>
      <subsection id="HCE26EC12EA9A4EA4A3C2B3297A163D9B">
        <enum>(c)</enum>
        <header>Experts and consultants</header>
        <text>With the approval of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>, the Director may procure temporary and intermittent services
			 under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="uscode" value="usc/5/3109/b">
            <external-xref legal-doc="usc" parsable-cite="usc/5/3109">section 3109(b)</external-xref> of title 5, United States Code</cato:entity-ref>.</text>
			</subsection>
      <subsection id="H1BB0CFE1AD2F42299B7C6123F18E25BD">
        <enum>(d)</enum>
        <header>Detail of government employees</header>
        <text>Upon the request of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>, the head of any Federal agency may detail, without
			 reimbursement, any of the personnel of such agency to the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> to
			 assist in carrying out the duties of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>. Any such detail shall
			 not interrupt or otherwise affect the civil service status or privileges
			 of the personnel.</text>
			</subsection>
    </section>
    <section id="HB474C7351A1E477E9B67F6D69A658B46">
      <enum>8.</enum>
      <header>Authorization of appropriations</header>
			<subsection commented="no" id="HFC1A632AED464F599927022BFB85AB00">
        <enum>(a)</enum>
        <header>In general</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">There is authorized to be appropriated <cato:funds-and-year amount="2000000">$2,000,000</cato:funds-and-year> <cato:property name="purpose">to carry out <cato:entity-ref entity-type="act" value="Western Hemisphere Drug Policy Commission Act of 2014" proposed="true">this Act</cato:entity-ref>
            </cato:property>.</cato:entity>
        </text>
			</subsection>
      <subsection id="H704760D505FF43868ADFB39A1402EA0B">
        <enum>(b)</enum>
        <header>Availability</header>
        <text>Amounts authorized to be appropriated under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Western Hemisphere Drug Policy Commission Act of 2014/s:8/ss:a" proposed="true">subsection (a)</cato:entity-ref> are authorized to remain available until
			 expended.</text>
			</subsection>
    </section>
    <section id="HCB822F0AC919420BBF13710A3D2037E9">
      <enum>9.</enum>
      <header>Offset</header>
      <text display-inline="no-display-inline">
        <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref entity-type="act" value="Enhanced Partnership with Pakistan Act of 2009/s:102/ss:a">Section 102(a) of the Enhanced Partnership with Pakistan Act of 2009</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/22/8412">
          <cato:entity-ref entity-type="uscode" value="usc/22/8412/a">22 U.S.C. 8412(a)</cato:entity-ref>
        </external-xref>; <cato:entity-ref entity-type="public-law" value="public-law/111/73">Public Law
			 111–73</cato:entity-ref>; <cato:entity-ref entity-type="statute-at-large" value="statute-at-large/123/2068">123 Stat. 2068</cato:entity-ref>)</cato:entity> is amended by striking <quote>$1,500,000,000</quote> and inserting <quote>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="auth-auth-approp">
            <cato:funds-and-year amount="-2000000" year="2010, 2011, 2012, 2013, 2014">$1,498,000,000</cato:funds-and-year>
          </cato:entity>
        </quote>.</text>
		</section>
    <section id="H776A056E8CF048A197394AC9EDC12C5D">
      <enum>10.</enum>
      <header>Sunset</header>
      <text display-inline="no-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref> shall terminate on the date that is 60 days after the date on which the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" value="Western Hemisphere Drug Policy Commission" proposed="true">Commission</cato:entity-ref>
			 submits its to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="0001">Congress</cato:entity-ref> of its report pursuant to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="act" value="Western Hemisphere Drug Policy Commission Act of 2014/s:4/ss:c" proposed="true">section 4(c)</cato:entity-ref>.</text>
		</section>
  </legis-body>
</bill>
</doc>